With LIM kinase upregulation, MAL (megakaryocytic acute leukemia) can no longer be sequestered by actin monomers and translocates to the nucleus, where it activates SRF (serum response factor), a factor that responds to morphological changes in the actin cytoskeleton. The gene discussed is SRF; the disease is acute megakaryoblastic leukemia.